Matthew Avery works on a range of IP matters at Baker Botts, focusing primarily on patent prosecution, counseling, and diligence. Matthew has experience in preparing and prosecuting patent applications relating to a wide range of technologies, including the medical device, biotechnology, pharmaceutical, chemical, clean tech, software and semiconductor arts. He also has experience in FDA regulatory matters, particularly dealing with the Hatch-Waxman Act, ANDA litigation, and the regulation of generic drugs. In addition to providing legal services for his clients, Matthew is also an Adjunct Professor at the University of California, Hastings College of the Law, where he teaches Food and Drug Law. He previously taught at Santa Clara University, School of Law.